What You Should Know:
- Octagos Health, a provider of AI-powered cardiac device monitoring solutions raises $43M in Series B funding led by funds managed by Morgan Stanley Expansion Capital with continued participation from Mucker Capital and other strategic investors.
- The investment fuels Octagos Health's mission to leverage artificial intelligence for transformative cardiac care and comprehensive patient monitoring.
AI-Powered Cardica Care
Octagos Health offers a
Read More
Cardiac Devices
Eko Launches Next Generation DUO ECG + Digital Stethoscope for Frontline Clinicians
What You Should Know:
- Eko, a cardiopulmonary digital health company launches its next-generation Eko DUO, an FDA-cleared cardiac assessment tool that functions as an electrocardiogram (ECG) and digital stethoscope to detect early signs of heart disease and facilitate timely care and personalized disease management.
- DUO is a pocket-sized cardiac examination system for clinicians used to detect early signs of heart disease and facilitate timely care for patients in and out of the clinic.
Read More
Eko Lands $65M to Expand AI-Powered Telehealth Platform for Virtual Pulmonary and Cardiac Exam
What You Should Know:
- Cardiopulmonary digital health company Eko raises $65M
in Series C funding to close the gap between virtual and in-person heart and
lung care.
- The latest round of funding will enable Eko to expand
in-clinic use of its platform of telehealth and AI algorithms for disease
screening and to launch a monitoring program for cardiopulmonary patients at
home.
Eko, a
cardiopulmonary digital
health company,
today announced $65 million in Series C funding led by
Read More
Eko Launches AI-Powered Telehealth Platform for Virtual Pulmonary and Cardiac Exam
What You Should Know:
Eko launches first AI-Powered telehealth platform for virtual
pulmonary and cardiac exams, providing clinicians with in-person level exam capabilities
during video visits.
Already deployed by more than 200 health systems for telehealth, platform goes beyond standard video conferencing to facilitate stethoscope audio, ECG live-streaming, and FDA-cleared identification of atrial fibrillation (AFib) and heart murmurs.
Eko today
announced Eko Telehealth, an
Read More
Do We Know When Medical Devices Fail?
Since 2015, the FDA and the US Department of Homeland Security have been releasing warnings about products that due to their vulnerabilities threaten patient safety. This includes MRI machines and drug infusion pumps that supply patients with a wide diversity of drugs, including insulin, antibiotics, chemotherapy drugs, and pain relievers. The interconnectivity of smart devices with medical clinical systems leaves them vulnerable to security breaches just like any other networked computing
Read More
FDA Clears AI-Powered EchoGo Core for Early Detection of Cardiovascular Disease
- Ultromics has just become one of the first companies to have 510(k) FDA clearance for an AI medical device. - EchoGo will now be available for clinicians in the UK and US to use to help them identify cardiovascular disease earlier. - EchoGo automates cardiac measurements and is the first AI application to measure cardiac strain, improving patient care and outcomes.Ultromics, the UK-based health technology firm at the forefront of applying artificial intelligence to echocardiography has
Read More
Cleveland Clinic Names Top 10 Medical Innovations for 2020
- Cleveland Clinic panel of top doctors and researchers presents the 10 medical innovations with the power to transform healthcare in the next year.
Today at the 2019 Medical Innovation Summit, Cleveland Clinic today announced the Top 10 Medical Innovations for 2020. The 17th annual Medical Innovation Summit is organized by Cleveland Clinic Innovations, the development, and commercialization arm of Cleveland Clinic. Led by Michael Roizen, M.D., Emeritus Chief Wellness Officer at Cleveland
Read More
Eko Raises $20M to Expand Machine Learning Platform for Cardiac Monitoring/Analysis
- AI-driven digital health startup Eko raises $20M led by ARTIS Ventures with participation from 3M and Mayo Clinic.
- Funding will be used to accelerate research and development (R&D) and commercialization of Eko’s machine learning platform for cardiac screening/analysis.
- Eko’s cardiac monitor combines digital stethoscope and ECG technology both for in-clinic and at-home monitoring, which enables patients to seamlessly and consistently send cardiac data to their
Read More
Vixiar Medical Nabs $1.5M to Expand Hand-Held Devices for Cardiac Monitoring
Vixiar Medical, Inc., a Baltimore, Maryland-based company dedicated to the development of non-invasive devices and systems for monitoring cardiopulmonary diseases has raised $1.5 million from new and existing investors. New investors joining in this round included Emerald Development Managers, MMG Opportunities and several individual investors. Existing investors included The Maryland Technology Development Corporation (TEDCO) through its seed fund, the Abell Foundation, individual investors and
Read More
Northwestern Medicine and Eko Launches AI Algorithms Heart Murmurs Study
Northwestern Medicine and Eko launches a new clinical study to validate algorithms that help providers more accurately screen for valvular heart disease with a digital stethoscopeToday Northwestern Medicine Bluhm Cardiovascular Institute and Eko have announced a partnership pioneering the use of artificial intelligence (AI) for cardiac screening in a new study of Eko’s cardiac monitoring platform. The study aims to demonstrate that Eko’s digital stethoscopes and AI algorithms can interpret heart
Read More
